Choose your location to get a site experience tailored for you.

Remember my region and language settings

Unsere neuesten Erkenntnissen über Biopharmaceuticals

Die Biotech- und Pharmabranche setzt ihre digitale Entwicklung mit hohem Tempo fort, während geopolitische und ökonomische Kräfte Probleme bereiten, die mithilfe einer die gesamte Lieferkette erfassenden und sorgfältig angepassten Strategie gelöst werden müssen. Erkunden Sie die aktuelle Vordenkerrolle von BCG im Bereich Biopharmaceuticals und gewinnen Sie wichtige Erkentnisse über die Zukunft der Life-Sciences-Branche.


Featured Insights

Health Care - PLAN for an Effective COVID-19 Response

PLAN for an Effective COVID-19 Response

Preparing Localities for Action Against Novel Coronavirus (PLAN) is a scenario-planning tool that identifies potential US supply and demand imbalances down to the county level.

COVID-19 and the New Leadership Agenda

The COVID-19 outbreak underscores the need to be resilient in the face of transformative global risk.

Winning the ’20s

How should leaders prepare their companies to thrive in the new decade?

Biopharmaceuticals - Getting a Grip on COGS in Generic Drugs

Getting a Grip on COGS in Generic Drugs

BCG’s 2019 benchmark study found that companies need to relentlessly manage the elements that demand the greatest spending—internal and contract manufacturing.

Biopharmaceuticals in Germany

Placing Your CAR-T Bets

Placing Your CAR-T Bets

These new therapies are poised to revolutionize oncology. It all depends on reaching a larger patient base and simplifying manufacturing and the supply chain.

Anticipating the Spread of COVID-19 with Scenario Planning

Anticipating the Spread of COVID-19 with Scenario Planning

Accelerating Drug Development Today

How to Lead a Digital Transformation: By Internal Disruption

BCG GAMMA's Transformative Work for an Oncology Center

Using Big Data to Help Fight Cancer

Innovation in Biopharma R&D

Externe Innovationsgrundlagen von einem F&E-Experten

Karalee Close on The Digital Opportunity in Healthcare

Frank Cordes on The Pharma Factory of the Future

Mark Lubkeman on A Return to Growth

protected by reCaptcha

Subscribe to our Biopharma eAlert.

(Bio) Pharma / Pharmaindustrie

ANMELDEN